Third Arc Bio
Develops novel multifunctional antibodies for oncology and immunology & inflammation indications
$52MSeries A+
Role not disclosedLoading investors…
Activity from announced rounds
Develops novel multifunctional antibodies for oncology and immunology & inflammation indications
Develops medicines targeting historically undruggable protein targets in cancer
Pitching Alderline Group? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room